# A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

> **NCT00959816** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ABT-614

## Key facts

- **NCT ID:** NCT00959816
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-08
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959816, "A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00959816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*